Registration of Additional Securities — Form S-3
Filing Table of Contents
Document/Exhibit Description Pages Size
1: S-3MEF Geltex Pharmaceuticals, Inc. 4 20K
2: EX-5.1 Opinion of Palmer & Dodge LLP 1 8K
3: EX-23.1 Consent of Ernst & Young LLP 1 7K
4: EX-23.2 Consent of Hamilton, Brook, Smith and Reynolds, Pc 1 5K
S-3MEF — Geltex Pharmaceuticals, Inc.
| S-3MEF | 1st Page of 4 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
|---|
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 18, 1998.
REGISTRATION NO. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
GELTEX PHARMACEUTICALS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
[Download Table]
DELAWARE 04-3136767
(STATE OR OTHER JURISDICTION (I.R.S. EMPLOYER
OF INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
NINE FOURTH AVENUE, WALTHAM, MASSACHUSETTS 02154 (781) 290-5888
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF
REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
------------------------
MARK SKALETSKY
PRESIDENT AND CHIEF EXECUTIVE OFFICER
GELTEX PHARMACEUTICALS, INC.
NINE FOURTH AVENUE
WALTHAM, MASSACHUSETTS 02154
(781) 290-5888
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF AGENT FOR SERVICE)
with copies to:
[Download Table]
MAUREEN P. MANNING, ESQ. STEVEN D. SINGER, ESQ.
PALMER & DODGE LLP PHILIP P. ROSSETTI, ESQ.
ONE BEACON STREET HALE AND DORR LLP
BOSTON, MASSACHUSETTS 02108 60 STATE STREET
(617) 573-0100 BOSTON, MASSACHUSETTS 02109
(617) 526-6000
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
As soon as practicable after the effective date of this Registration Statement.
------------------------
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [X] No. 333-45151.
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
CALCULATION OF REGISTRATION FEE
--------------------------------------------------------------------------------
[Enlarge/Download Table]
------------------------------------------------------------------------------------------------------------------
PROPOSED MAXIMUM
TITLE OF SHARES AGGREGATE AMOUNT OF
TO BE REGISTERED OFFERING PRICE REGISTRATION FEE
------------------------------------------------------------------------------------------------------------------
Common Stock, $.01 par value......................... $8,150,000 $2,405
==================================================================================================================
------------------------
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a),
MAY DETERMINE.
================================================================================
This registration statement is being filed with respect to the registration of
additional shares of Common Stock, $.01 par value per share, of GelTex
Pharmaceuticals, Inc., a Delaware corporation, (the "Company") for an offering
pursuant to Rule 462(b) under the Securities Act of 1933, as amended. The
contents of the Company's earlier effective registration statement (File No.
333-45151) are incorporated in this registration statement by reference.
The required opinions and consents are listed on an Exhibit Index attached
hereto and filed herewith.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Waltham, Commonwealth of Massachusetts, on March 18,
1998.
GELTEX PHARMACEUTICALS, INC.
By: /s/ PAUL J. MELLETT, JR.
------------------------------------
and Finance
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
[Enlarge/Download Table]
SIGNATURE TITLE
--------- -----
* President (Principal Executive March 18, 1998
--------------------------------------------------- Officer) and Director
Mark Skaletsky
/s/ PAUL J. MELLETT, JR. Vice President March 18, 1998
--------------------------------------------------- Administration and Finance
Paul J. Mellett, Jr. (Principal Financial and
Accounting Officer)
* Chairman of the Board and March 18, 1998
--------------------------------------------------- Director
Robert J. Carpenter
* Director March 18, 1998
---------------------------------------------------
J. Richard Crout
* Director March 18, 1998
---------------------------------------------------
Henri A. Termeer
* Director March 18, 1998
---------------------------------------------------
Jesse Treu
* Director March 18, 1998
---------------------------------------------------
George M. Whitesides
*By: /s/ PAUL J. MELLETT, JR.
---------------------------------------------
Attorney-in-fact
3
EXHIBIT INDEX
[Download Table]
EXHIBIT
NO. DESCRIPTION
------- -----------
5.1 Opinion of Palmer & Dodge LLP.
23.1 Consent of Ernst & Young LLP, independent auditors to
Company.
23.2 Consent of Hamilton, Brook, Smith and Reynolds, P.C.
23.3 Consent of Palmer & Dodge LLP. Included in Exhibit 5.1.
24.1 Power of Attorney.*
---------------
* Filed as Exhibit 24.1 to the Company's Registration Statement on Form S-3
(Registration No. 333-45151) filed on January 29, 1998 and incorporated herein
by reference.
Dates Referenced Herein and Documents Incorporated by Reference
| Referenced-On Page |
|---|
| This ‘S-3MEF’ Filing | | Date | | First | | Last | | | Other Filings |
|---|
| |  |
| Changed as of / Corrected on: | | 3/20/98 | | | | | | | 424B1 |
| Effective on: | | 3/19/98 |
| Filed on: | | 3/18/98 | | 1 | | 3 |
| | 1/29/98 | | 4 | | | | | S-3 |
| List all Filings |
↑Top
Filing Submission 0000950135-98-001642 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Wed., May 15, 4:58:02.0pm ET 